Signaling mechanisms of vasoactive intestinal peptide in inflammatory conditions.

Signaling mechanisms of vasoactive intestinal peptide in inflammatory conditions.

Item
http://www.wikidata.org/entity/Q36584206
A Bayesian latent class analysis for whole-genome association analyses: an illustration using the GAW15 simulated rheumatoid arthritis dense scan dataDistinct signaling cascades elicited by different formyl peptide receptor 2 (FPR2) agonistsCombined administration of secretin and oxytocin inhibits chronic colitis and associated activation of forebrain neurons.VIPhyb, an antagonist of vasoactive intestinal peptide receptor, enhances cellular antiviral immunity in murine cytomegalovirus infected mice.Vasoactive intestinal peptide downregulates proinflammatory TLRs while upregulating anti-inflammatory TLRs in the infected cornea.Tuning immune tolerance with vasoactive intestinal peptide: a new therapeutic approach for immune disordersVPAC1 receptor (Vipr1)-deficient mice exhibit ameliorated experimental autoimmune encephalomyelitis, with specific deficits in the effector stage.Transcriptional and translational plasticity in rodent urinary bladder TRP channels with urinary bladder inflammation, bladder dysfunction, or postnatal maturation.Protected graft copolymer excipient leads to a higher acute maximum tolerated dose and extends residence time of vasoactive intestinal Peptide significantly better than sterically stabilized micelles.Anti-inflammatory neuropeptides: a new class of endogenous immunoregulatory agentsUrinary bladder function and somatic sensitivity in vasoactive intestinal polypeptide (VIP)-/- miceExaggerated expression of inflammatory mediators in vasoactive intestinal polypeptide knockout (VIP-/-) mice with cyclophosphamide (CYP)-induced cystitis.Expression of phosphorylated cAMP response element binding protein (p-CREB) in bladder afferent pathways in VIP-/- mice with cyclophosphamide (CYP)-induced cystitis.Administration of a vasoactive intestinal peptide antagonist enhances the autologous anti-leukemia T cell response in murine models of acute leukemia.Levels of dipeptidyl peptidase IV/CD26 substrates neuropeptide Y and vasoactive intestinal peptide in rheumatoid arthritis patients.Neuroendocrine cells derived chemokine vasoactive intestinal polypeptide (VIP) in allergic diseases.Modulation of Immune Checkpoints and Graft-versus-Leukemia in Allogeneic Transplants by Antagonizing Vasoactive Intestinal Peptide Signaling.
P2860

Signaling mechanisms of vasoactive intestinal peptide in inflammatory conditions.

Item
http://www.wikidata.org/entity/Q36584206
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Signaling mechanisms of vasoactive intestinal peptide in inflammatory conditions.
@ast
Signaling mechanisms of vasoactive intestinal peptide in inflammatory conditions.
@en
type
label
Signaling mechanisms of vasoactive intestinal peptide in inflammatory conditions.
@ast
Signaling mechanisms of vasoactive intestinal peptide in inflammatory conditions.
@en
prefLabel
Signaling mechanisms of vasoactive intestinal peptide in inflammatory conditions.
@ast
Signaling mechanisms of vasoactive intestinal peptide in inflammatory conditions.
@en
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P356
P1433
P1476
Signaling mechanisms of vasoactive intestinal peptide in inflammatory conditions
@en
P2093
P304
P31
P356
10.1016/J.REGPEP.2006.04.021
P433
P478
P50
P577
P5875
P698